Therefore, we aimed to explore genes that may be predictive factors for the efficacy of eradication therapy in API2-MALT1-negative and Hp-negative gastric MALT lymphoma cases, based on a comprehensive analysis using RNA sequencing. This evidence concerns the gene BIRC3 and gastric mucosa-associated lymphoid tissue lymphoma.